2005年2月第2期
·07/05/10 Options for Recanalization Therapy in Basilar Artery Occlusion
·07/05/10 Telephone Assessment of Stroke Outcome Is Reliable
·07/05/10 Critical Care and Emergency Medicine Neurology in Stroke
·07/05/10 Emerging Therapies for Cerebrovascular Disorders
·07/05/10 Advances in Interventional Neuroradiology 2004
·07/05/10 What’s New in Stroke Rehabilitation
·07/05/10 Secondary Prevention of Recurrent Stroke
·07/05/10 Prevention and Health Services Delivery
·07/05/10 Health Policy and Outcomes Research 2004
·07/05/10 Influence of Dietary Patterns on Stroke Risk in China
·07/05/10 Risk Factors for Stroke in Subjects With Normal Blood Pressure
·07/05/10 Outdoor Air Pollution and Stroke in Sheffield, United Kingdom
·07/05/10 Update on the Genetics of Stroke and Cerebrovascular Disease 2004
·07/05/10 Trends in Fatal and Nonfatal Strokes Among Persons Aged 35 to 85 Years During 1991–2002 in Finland
·07/05/10 Role of the Interleukin-6 –174 G>C Gene Polymorphism in Retinal Artery Occlusion
·07/05/10 Thrombosis, Ulceration, and Stroke Pathogenesis
·07/05/10 A Case-Control Study on the Infectious Burden of Atypical Respiratory Pathogens in Elderly Patients With Acute Cerebrovascular Disease
·07/05/10 Blood Pressure and Vessel Recanalization in the First Hours After Ischemic Stroke
·07/05/10 Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide in Acute Ischemic Stroke Do Not Relate to Clinical Prognosis
·07/05/10 Biological Assessment of Aspirin Efficacy on Healthy Individuals
·07/05/10 Restenosis After Carotid Angioplasty, Stenting, or Endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS)
·07/05/10 The Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria
·07/05/10 A Safe Adjunct to Thrombolytic Therapy in Acute Stroke
·07/05/10 The Janus Face of Cyclooxygenase-2 in Ischemic Stroke
·07/05/10 A Randomized Controlled Trial of Early Supported Discharge and Continued Rehabilitation at Home After Stroke
·07/05/10 Influence of Socioeconomic Status on Mortality After Stroke
·07/05/10 Preference-Based Quality of Life in Patients With Cerebral Aneurysms
·07/05/10 Are There Inequalities in the Provision of Stroke Care
·07/05/10 Folate Deficiency Increases Postischemic Brain Injury
·07/05/10 Albumin Treatment Reduces Neurological Deficit and Protects Blood–Brain Barrier Integrity After Acute Intracortical Hematoma in the Rat
·07/05/10 Aggravation of Focal Cerebral Ischemia by Tissue Plasminogen Activator Is Reversed by 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor but Does Not Depend on Endothelial NO Synthase
·07/05/10 Estradiol Regulates Angiopoietin-1 mRNA Expression Through Estrogen Receptor- in a Rodent Experimental Stroke Model
·07/05/10 Impaired Endothelium-Dependent Responses and Enhanced Influence of Rho-Kinase in Cerebral Arterioles in Type II Diabetes
·07/05/10 Holo-Transferrin and Thrombin Can Interact to Cause Brain Damage
·07/05/10 The Curse That Underlies Cerebral Vascular Dysfunction
·07/05/10 Telephone Assessment of Stroke Outcome Is Reliable
·07/05/10 Critical Care and Emergency Medicine Neurology in Stroke
·07/05/10 Emerging Therapies for Cerebrovascular Disorders
·07/05/10 Advances in Interventional Neuroradiology 2004
·07/05/10 What’s New in Stroke Rehabilitation
·07/05/10 Secondary Prevention of Recurrent Stroke
·07/05/10 Prevention and Health Services Delivery
·07/05/10 Health Policy and Outcomes Research 2004
·07/05/10 Influence of Dietary Patterns on Stroke Risk in China
·07/05/10 Risk Factors for Stroke in Subjects With Normal Blood Pressure
·07/05/10 Outdoor Air Pollution and Stroke in Sheffield, United Kingdom
·07/05/10 Update on the Genetics of Stroke and Cerebrovascular Disease 2004
·07/05/10 Trends in Fatal and Nonfatal Strokes Among Persons Aged 35 to 85 Years During 1991–2002 in Finland
·07/05/10 Role of the Interleukin-6 –174 G>C Gene Polymorphism in Retinal Artery Occlusion
·07/05/10 Thrombosis, Ulceration, and Stroke Pathogenesis
·07/05/10 A Case-Control Study on the Infectious Burden of Atypical Respiratory Pathogens in Elderly Patients With Acute Cerebrovascular Disease
·07/05/10 Blood Pressure and Vessel Recanalization in the First Hours After Ischemic Stroke
·07/05/10 Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide in Acute Ischemic Stroke Do Not Relate to Clinical Prognosis
·07/05/10 Biological Assessment of Aspirin Efficacy on Healthy Individuals
·07/05/10 Restenosis After Carotid Angioplasty, Stenting, or Endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS)
·07/05/10 The Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria
·07/05/10 A Safe Adjunct to Thrombolytic Therapy in Acute Stroke
·07/05/10 The Janus Face of Cyclooxygenase-2 in Ischemic Stroke
·07/05/10 A Randomized Controlled Trial of Early Supported Discharge and Continued Rehabilitation at Home After Stroke
·07/05/10 Influence of Socioeconomic Status on Mortality After Stroke
·07/05/10 Preference-Based Quality of Life in Patients With Cerebral Aneurysms
·07/05/10 Are There Inequalities in the Provision of Stroke Care
·07/05/10 Folate Deficiency Increases Postischemic Brain Injury
·07/05/10 Albumin Treatment Reduces Neurological Deficit and Protects Blood–Brain Barrier Integrity After Acute Intracortical Hematoma in the Rat
·07/05/10 Aggravation of Focal Cerebral Ischemia by Tissue Plasminogen Activator Is Reversed by 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor but Does Not Depend on Endothelial NO Synthase
·07/05/10 Estradiol Regulates Angiopoietin-1 mRNA Expression Through Estrogen Receptor- in a Rodent Experimental Stroke Model
·07/05/10 Impaired Endothelium-Dependent Responses and Enhanced Influence of Rho-Kinase in Cerebral Arterioles in Type II Diabetes
·07/05/10 Holo-Transferrin and Thrombin Can Interact to Cause Brain Damage
·07/05/10 The Curse That Underlies Cerebral Vascular Dysfunction